about us

Emerge Health Pty Ltd is an innovative, specialised Australian pharmaceutical company focused on the marketing and sales of niche, high quality medicines to the hospital sector. Emerge Health is dedicated to providing exceptional products and support to ensure we meet our customers and partners needs and priorities.

Emerge Health has a unique, highly experienced management team with a track record of success in the Australian and New Zealand pharmaceutical markets. Our goal is to develop long term valuable relationships with suppliers and customers and to build trust through working collaboratively with our partners.

Products supplied include those that 

• provide safe effective solutions to critical and emergency care situations;
  
• medicines that fulfil orphan drug designation, thereby treating rare diseases in the Australian population
• are considered a low priority for the multinational pharmaceutical companies.

Emerge Health strives to fast track the marketing approval and reimbursement process where use and adoption is driven by unmet or poorly satisfied clinical needs of the most difficult patients, who are under the care of hospital specialists.

Mission

Vision

PEOPLE FIRST | We focus on the needs of patients and their healthcare professionals

POWERED WITH PASSION | Believing in everything we do, we can make a difference

PARTNER OF CHOICE | Offering partners a contemporary approach, tailoring our service to their needs in Australia, New Zealand and the Asia Pacific region

PERSONALISED SERVICE | Positive experiences with our customers every day

The Founders of Emerge Health

The Emerge Health management team has over 50 years experience in the Australian Pharmaceutical sector, with vast experience and expertise in new product registration and launch

• product access and commercialisation (sales and marketing),
• local and international business development, and
• pricing and reimbursement which is particularly important for market access in the very price sensitive Australian market. 

Chris Rossidis

Head of Commercial Operations: Chris has proven leadership, developing business strategies within the pharmaceutical, biotech, and medical device sectors.

Chris Rossidis has more than seventeen years of leadership, developing business strategies within the pharmaceutical, biotech, and medical device sectors. His background includes business development/licensing, strategy development and implementation, general management, sales, marketing, full financial control, process and systems improvement as well as governance leadership.

A person of professional standing, integrity and intellectual authority, Chris is a strategic thinker with a decisive leadership style and creative approach to solving business challenges. Significant recent achievements include the restructure of a medium sized ASX listed healthcare company, implementing a comprehensive change management programme, developing a new business model for sustainable future growth. Chris boasts high level commercial competencies, building growth globally in a highly competitive marketplace. Building international licensing and partnership agreements, Chris is an expert client relationship leader leveraging off successes into new markets.

Chris possesses a strong strategic approach to functional issues with excellent operational expertise.

Peter Davey

Head of Pricing and Market Access: Peter has over 20 years experience in price and market access in Australia and internationally and has a track record in the successful start up and running of new businesses

Peter Davey has extensive experience in pharmaceutical pricing, reimbursement and research based activities involved over the product life cycle. From 1995 to 2005 he co-founded and ran Australia’s largest pricing and reimbursement consultancy, employing 45 staff in offices located in Sydney and London. After it was acquired by IMS Health, Peter was appointed the IMS Principal for Pricing and Market Access for Asia Pacific and Japan.

Through these roles he worked with all the major multinational pharmaceutical companies and consulted through Australasia, Europe, Asia and the Middle East. He has been heavily involved with company teams working on the launch of new products and has worked on over 300 new pharmaceutical products. He has spoken widely at international conferences and has been a member of Australia Government committees overseeing funding and research.

Over the past 3 years he has worked in product licensing and pharmaceutical policy, with a focus on pricing and health services practice.

If you would like to explore partnering opportunities with Emerge Health, please contact us.